The IMF has created the Latin American Myeloma Network (LAMN) to conduct multinational trials, provide myeloma education to patients and providers, facilitate collaborative research, and deepen the myeloma expertise across the region of Latin America. It also serves to bring Latin American expertise to the wider global program of the IMF, including the IMF International Myeloma Working Group.
Current member countries of the LAMN include top myeloma investigators from Argentina, Brazil, Chile, Colombia, and Uruguay. The first clinical trial LAMN001 is soon to be launched for early relapsed disease.